Send us a text

Bill Taranto is President of both the Merck Global Health Innovation Fund ( MGHIF - https://www.merckghifund.com/ ), and Merck Global Health Private Equity (GHIPE). He is the founder of MGHIF and is responsible for leading the global health capability for Merck ( https://www.merck.com/ ). The Merck Global Health Innovation Fund was established in late 2010 as a strategic response to the challenges surrounding Merck’s core business of discovering, developing and marketing innovative drugs and vaccines. MGHIF is a $500m evergreen fund focused on identifying opportunities that are adjacent to Merck’s core business of pharmaceuticals and vaccines. Under Bill's leadership, MGHIF has invested more than $1bn in 70 companies, with more than $7bn in exits. Bill has more than three decades of experience in the healthcare industry. Prior to joining Merck, he spent 18 years at Johnson & Johnson (J&J) in various roles. As VP of healthcare strategy and venture at J&J, he was responsible for evaluating and creating new healthcare business models through venture capital and acquisitions. Prior to joining J&J, he spent eight years in investment banking. 

Support the show